Eesti - eesti - Ravimiamet

fresenius kabi oncology plc - kapetsitabiin - õhukese polümeerikattega tablett - 500mg 120tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

novartis europharm limited  - brolucizumab - märg macula degeneration - oftalmoloogilised vahendid - beovu on näidustatud täiskasvanute raviks neovascular (märg) vanusega seotud makuladegeneratsiooni (amd).

Euroopa Liit - eesti - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipiidi modifitseerivad ained - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Euroopa Liit - eesti - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - kartsinoom, mitteväikerakk-kopsu - antineoplastilised ained - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Eesti - eesti - Ravimiamet

desitin arzneimittel gmbh - valproehape - suukaudne lahus - 60mg 1ml 250ml 1tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - valproehape - siirup - 50mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 22,7mg 1ml 2.5l 5tk; 22,7mg 1ml 1.5l 6tk; 22,7mg 1ml 2.5l 4tk; 22,7mg 1ml 2l 5tk

Eesti - eesti - Ravimiamet

oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 38,6mg 1ml 2.5l 5tk; 38,6mg 1ml 2.5l 4tk; 38,6mg 1ml 2l 4tk; 38,6mg 1ml 2l 5tk

Eesti - eesti - Ravimiamet

oÜ baxter estonia - hüpertoonilised lahused - peritoneaaldialüüsilahus - 13,6mg 1ml 2l 5tk; 13,6mg 1ml 2.5l 5tk; 13,6mg 1ml 1.5l 5tk; 13,6mg 1ml 1.5l 6tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - talidomiid - mitu müeloomit - immunosupressandid - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.